Berkeley Conversations: Reopening and reimagining after COVID-19
What measures can be put into place to make sure it’s safe for all Americans to get back to school, work, and public spaces? Will there really be a vaccine ready by November? When there is a vaccine, who’ll get it first and how long will it take to achieve herd immunity? How can cutting-edge tools like machine learning and artificial intelligence be used to speed the discovery of new drugs? What will it take to create a global early warning system that allows early curtailment of the next pandemic?
As part of the Berkeley Conversations: COVID-19 series of live webcasts, Berkeley School of Public Health Dean Michael C. Lu moderated a panel of experts in epidemiology, infectious diseases, vaccinology, biostatistics, and genome research to answer the questions on all of our minds about how we can re-open safely and reimagine how we will tackle future pandemics.
Michael Marletta, PhD, UC Berkeley College of Chemistry professor of chemistry and molecular and cell biology and CH and Annie Li Chair in the Molecular Biology of Diseases
Maya Petersen, MD, PhD, UC Berkeley School of Public Health associate professor of epidemiology and biostatistics and chair of the Division of Biostatistics
Arthur Reingold, MD, UC Berkeley School of Public Health professor of epidemiology and chair of the Division of Epidemiology
John Swartzberg, MD, FACP, UC Berkeley School of Public Health clinical professor emeritus, Infectious Diseases and Vaccinology